NLME-NONMEM model comparisons
Examples of PK and PK/PD models using PML (NLME) and NMTRAN (NONMEM)
Pinned
Introduction to Phoenix Model Interface and comparison with NONMEMStarted by Christopher Mehl , 13 Jan 2017 |
|
|
||
Non linear PK between and within dose levelsStarted by nileshg , 20 Feb 2023  Bioavailability
|
|
|
||
POPPK model using single concentration dataStarted by vk_pharmacy , 11 Feb 2019 |
|
|
||
PD Categorical ResponseStarted by bwendt@certara.com , 23 Nov 2018 NONMEM, NLME, Categorical
|
|
|
||
NONMEM fails at TMDD ModelingStarted by frrd@lundbeck.com , 28 May 2021 TMDD modeling
|
|
|
||
Phoenix NLME outputStarted by Gilles TUFFAL , 29 Apr 2021 RSE, CV%
|
|
|
||
Emax model using and comapring FOCE ELS/FOCE LB/QRPEM/IT2S_EMStarted by joybaker , 22 Sep 2020 |
|
|
||
File does not exist "NLME7.exe"Started by jzq90 , 17 Apr 2020 |
|
|
||
NONMEM versus Phoenix NLME: Discontinuity in differential equationStarted by Pradeepsharma , 12 Feb 2020 |
|
|
||
*.cov and *.ext filesStarted by youssefmousa , 27 Dec 2019 |
|
|
||
Simulation results of different dosingStarted by sundar , 19 Jun 2019 PKPD modeling
|
|
|
||
Performing the VPC of categorical covariateStarted by gwchoi , 14 Jun 2019 |
|
|
||
Another comparison of results NLME vs NOMEMStarted by jjohnl , 15 May 2019 |
|
|
||
PK 2 Compartment Mixed Absorption Multiple DoseStarted by bwendt@certara.com , 16 Dec 2017 NONMEM, NLME, PML and 2 more...
|
|
|
||
Re-estimate NONMEM model parameter values in Phoenix - IssueStarted by MojDa01 , 16 Mar 2018 |
|
|
||
Quantitative comparison of NONMEM modelsStarted by mondermm , 23 Jul 2018 NONMEM and 3 more...
|
|
|
||
ETA shrinkageStarted by Go-Wun Choi , 12 Jul 2018 |
|
|
||
Parameter estimates don't converge with a multiplicative modelStarted by david.reith@otago.ac.nz , 03 Jul 2018 |
|
|
||
posterior bayes simulationStarted by ysong24 , 29 Mar 2018 |
|
|
||
PKPD: 1 Compartment-IV Infusion - Emax with Baseline, Shape and EffectStarted by bwendt@certara.com , 20 Dec 2017 NONMEM, NLME, PKPD, Effect
|
|
|
||
PD Emax stimulatory with baselineStarted by bwendt@certara.com , 29 Dec 2017 NONMEM, NLME, Emax, Naseline
|
|
|
||
PD Indirect Response with IV Bolus DosingStarted by bwendt@certara.com , 20 Dec 2017 NONMEM, NLME, Indirect Response and 1 more...
|
|
|
||
PD Emax inhibitory with baseline and shape factorStarted by bwendt@certara.com , 20 Dec 2017 NONMEM, NLME, Emax
|
|
|
||
PK 2 Compartment Oral FOCEStarted by bwendt@certara.com , 16 Dec 2017 NONMEM, NLME, PML, Oral
|
|
|
||
PK 3 Compartment IV Infusion ExponentsStarted by bwendt@certara.com , 16 Dec 2017 NONMEM, PML, NLME, IV Infusion
|
|
|
||
PK 3 Compartment IV Bolus ExponentsStarted by bwendt@certara.com , 08 Dec 2017 NONMEM, NLME, IV Bolus
|
|
|
||
PK 1 Compartment IV Infusion CovariateStarted by bwendt@certara.com , 01 Dec 2017 NONMEM, PML, IV, Infusion and 1 more...
|
|
|
||
PK 1 compartment IV infusion coefficients and exponentsStarted by bwendt@certara.com , 30 Nov 2017 NONMEM, IV, Infusion and 2 more...
|
|
|
||
Population PKPD with Emax dependent on AUCtStarted by Christopher Mehl , 20 Jul 2017 |
|
|
||
PK Inhibitory Emax 1 compartment Oral dosing QRPEM/IMPStarted by Christopher Mehl , 19 Jul 2017 |
|
|
